FDA Approves First Generic Versions Of Antidepressant Drug Cymbalta

The Food and Drug Administration Dec. 11 approved the first generic versions of Eli Lilly’s Cymbalta (duloxetine delayed-release capsules), a prescription medicine used to treat depression and other conditions.

Aurobindo Pharma Ltd., Dr. Reddy’s Laboratories Ltd., Lupin Ltd., Sun Pharma Global FZE, Teva Pharmaceuticals USA and Torrent Pharmaceuticals Ltd. received approval to market duloxetine in various strengths, the agency said.

“Health care professionals and consumers can be assured that these FDA-approved generic drugs have met our rigorous standards,” said Kathleen Uhl, acting director of the Office of Generic Drugs in the FDA’s Center for Drug Evaluation and Research. “Generic drugs ...